OMIC
MRNA icon

Old Mission Investment Co’s Moderna MRNA Stock Holding History

Old Mission Investment Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,181
Closed -$203K – 109
2022
Q1 		$203K Buy
1,181
+100
+9% +$16.8K 0.08% 110
2021
Q4 		$275K Sell
1,081
-50
-4% -$14.6K 0.1% 99
2021
Q3 		$435K Hold
1,131
– – 0.18% 71
2021
Q2 		$266K Buy
+1,131
New +$202K 0.11% 90

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Old Mission Investment Co's MRNA Position: Q2 2022 in Review

Old Mission Investment Co sold out of Moderna (MRNA) in Q2 2022, closing a stake of 1,181 shares — an estimated $203K sold.

Old Mission Investment Co first reported a position in MRNA in Q2 2021 and held it in 4 quarters. The position peaked at $435K in Q3 2021. 980 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Old Mission Investment Co reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Old Mission Investment Co sold 1,181 Moderna shares in Q2 2022, an estimated $203K.
  • Old Mission Investment Co first reported a position in Moderna in Q2 2021 and held it in 4 quarters.
  • Old Mission Investment Co's Moderna position peaked at $435K in Q3 2021.
  • 980 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Old Mission Investment Co's 13F filing for Q2 2022, filed 16 Sep 2026.